Aspen Pharmacare Revenue and Competitors

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Aspen Pharmacare's estimated annual revenue is currently $257.5M per year.(i)
  • Aspen Pharmacare's estimated revenue per employee is $201,000

Employee Data

  • Aspen Pharmacare has 1281 Employees.(i)

Aspen Pharmacare's People

NameTitleEmail/Phone
1
Chief Audit ExecutiveReveal Email/Phone
2
CFO and Commerical Executive: Asia PacificReveal Email/Phone
3
Chief StaffReveal Email/Phone
4
CFOReveal Email/Phone
5
HR OfficerReveal Email/Phone
6
Validation OfficerReveal Email/Phone
7
Validation OfficerReveal Email/Phone
8
Compliance OfficerReveal Email/Phone
9
Compliance OfficerReveal Email/Phone
10
Validation OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Aspen Pharmacare?

With a 160-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets with approximately 10 000 employees at 70 established business operations in 55 countries.\n\nWe improve the health of patients in more than 150 countries through our high quality, affordable products. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products.\n\nOur manufacturing capabilities cover a wide variety of product types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients. We operate 23 manufacturing facilities across 15 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines.

keywords:N/A

N/A

Total Funding

1281

Number of Employees

$257.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aspen Pharmacare News

2022-04-17 - Aspen In Talks With African Leaders on Low Covid Vaccine Orders

Aspen Pharmacare Holdings Ltd. is in talks with African leaders about how to raise demand for Covid-19 vaccines after the continent's...

2022-04-13 - Lack of orders could halt COVID-19 vaccine production in South Africa

An Aspen Pharmacare facility for manufacturing Johnson & Johnson's COVID-19 vaccine in Port Elizabeth, South Africa, in October 2021.

2022-04-13 - Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Short ...

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Short Interest Update. Posted by admin on Apr 14th, 2022. Share on Twitter Share on Facebook Share on...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$407.1M12810%N/A
#2
$484.6M12825%N/A
#3
$395.8M128556%N/A
#4
$369.4M128711%N/A
#5
$431M128815%N/A